SEC Filing Analysis: Performant Healthcare Inc (PHLT)

Executive Summary

• Trading Significance: High
• Key Takeaway: A Director disposed of their entire holdings, valued at over $3.5 million, as a required step in the company's acquisition by Continental Buyer, Inc.
• Market Impact: This filing is a procedural confirmation of the merger's execution. It does not reflect a change in insider sentiment but rather the finalization of a major corporate action.

Company Information

Field	Value
Company	Performant Healthcare Inc
Ticker Symbol	PHLT
CIK	0001550695
Industry	Services-Miscellaneous Business Services

Insider Information

Field	Value
Name	LaCamp James
CIK	0001794194
Title/Position	null
Relationship	Director

Transaction Details

This filing reports the disposition of two types of securities pursuant to a merger agreement.

Field	Common Stock	Restricted Stock Units (RSUs)
Form Type	4	4
Transaction Date	2025-10-21	2025-10-21
Transaction Code	D (Disposition)	D (Disposition)
Shares Involved	417,220	35,616
Price Per Share	$7.75	$7.75
Total Value	$3,233,455	$276,024
Shares Owned After	0	0
Ownership Type	Direct	Direct

Financial Impact Assessment

Transaction Materiality (Combined)

Metric	Value
Total Transaction Value	$3,509,479
% of Market Cap	0.58%
Total Shares Transacted	452,836
% of Shares Outstanding	0.56%
Post-Transaction Ownership	0 shares (0.0% of outstanding)
Materiality Assessment	Highly Significant

Impact Evaluation

• Market Cap Context: For a company with a $610 million market cap, a $3.5 million transaction is notable. The disposition represents 0.58% of the company's market capitalization.
• Ownership Concentration: The Director has liquidated 100% of their holdings, reducing their ownership to zero. This is a direct and expected consequence of the cash-out merger.
• Dilution Impact: Not applicable, as this is a disposition of existing shares, not an issuance of new equity.
• Transaction Significance: The transaction is rated Highly Significant because the number of shares involved (0.56%) exceeds the 0.5% threshold for high materiality. The nature of the event—a complete liquidation due to a merger—is also inherently significant.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: This filing is a lagging indicator of a previously announced merger. The transaction is mechanical and required by the merger terms. It provides no new forward-looking information about the business itself, which is now a subsidiary of Continental Buyer, Inc.

Volume & Sentiment

• Expected Volume Impact: Negligible. The stock is likely halted or delisted post-merger. This filing simply formalizes the transfer.
• Sentiment Indicator: Neutral. This is not a discretionary sale based on the insider's outlook. It is a forced liquidation due to a corporate acquisition, which is a neutral signal regarding the insider's personal sentiment.

Investment Insights

Positive Market Indicators

• The merger was completed, providing a cash payout of $7.75 per share to all shareholders, which may represent a premium over the pre-announcement trading price.

Risk Factors

• The primary 'risk' or factor for public investors is that Performant Healthcare is no longer a publicly traded entity, eliminating future investment opportunities in the stock.

Key Takeaways

1. A Director disposed of over $3.5 million in stock and RSUs.
2. The transaction was not an open-market sale but a mandatory cash-out due to the company's acquisition.
3. The filing confirms the finalization of the merger agreement dated July 31, 2025, and the liquidation of the insider's position at the agreed-upon price of $7.75 per share.

Additional Context

Special Circumstances

• As detailed in the filing's footnotes, the disposition occurred pursuant to an Agreement and Plan of Merger. Each share of common stock and outstanding RSU was canceled and converted into the right to receive $7.75 in cash.